Besremi Achieves Strong Market Growth Amid Rising Demand For Polycythemia Vera Treatment
BESREMi is a preferred, FDA-approved option for both symptomatic low- and high-risk polycythemia vera patients. In the polycythemia vera space, BESRE ...
FiercePharma1d
Merck KGaA’s EMD Serono taps Selma Blair to join long-running campaign for MS drug Mavenclad
Merck KGaA’s U.S. pharma arm has recruited actor Selma Blair for a collaboration around multiple sclerosis treatment Mavenclad. | No cruel intentions here: Merck KGaA’s U.S. pharma arm has recruited ...
FierceBiotech1d
Incyte pens $885M biobucks AI pact to use Genesis' GEMS to develop new drugs
“Partnering with Genesis Therapeutics presents a unique opportunity to leverage their AI technologies to accelerate the ...
FierceBiotech2d
Merck pens $300M-per-product collab with Epitopea to locate 'hidden' tumor antigens
Merck & Co. has penned a $300 million biobucks-per-product deal with cancer biotech Epitopea to identify previously secret ...
PharmiWeb3d
Injectable Drug Delivery Market Set for Significant Growth, Projected to Reach USD 113.87 Billion by 2034 at a 8.70% of CAGR
Injectable Drug Delivery MarketThe global injectable drug delivery market is estimated to be valued at USD 49.44 billion in 2024, with strong growth expectations due to advancements in healthcare, ...